[Federal Register Volume 64, Number 45 (Tuesday, March 9, 1999)]
[Notices]
[Pages 11509-11510]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-5750]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Consolidated Guidance About Materials Licenses: Program-Specific 
Guidance About Commercial Radiopharmacy Licenses, Availability of Draft 
NUREG

AGENCY: Nuclear Regulatory Commission (NRC).

ACTION: Notice of availability and request for comments.

-----------------------------------------------------------------------

SUMMARY: The NRC is announcing the availability of and requesting 
comment on draft NUREG-1556, Volume 13, ``Consolidated Guidance about 
Materials Licenses: Program-Specific Guidance about Commercial 
Radiopharmacy Licenses,'' dated December 1998.
    NRC is using Business Process Redesign (BPR) techniques to redesign 
its materials licensing process, as described in NUREG-1539, 
``Methodology and Findings of the NRC's Materials Licensing Process 
Redesign.'' A critical element of the new process is consolidating and 
updating numerous guidance documents into a NUREG-series of reports. 
This draft NUREG report is the 13th program-specific guidance developed 
to support an improved materials licensing process.
    The guidance is intended for use by applicants, licensees, NRC 
license reviewers, and other NRC personnel. This document combines and 
updates the guidance found in ``Draft Regulatory Guide DG-0006'' 
(previously issued as FC 410-4), ``Guide for the Preparation of 
Applications for Commercial Nuclear Pharmacy Licenses'' (March 1997), 
and Standard Review Plan 85-14, ``Standard Review Plan for Applications 
for Nuclear Pharmacy Licenses.'' This draft report takes a more risk-
informed, performance-based approach to licensing commercial 
radiopharmacies and reduces the information (amount and level of 
detail) needed to support an application to use these devices. Note 
that this document is strictly for public comment and is not for use in 
preparing or reviewing commercial radiopharmacy licenses until it is 
published in final form. It is being distributed for comment to 
encourage public participation in its development.

DATES: The comment period ends June 7, 1999. Comments received after 
that time will be considered if practicable.

ADDRESSES: Submit written comments to: Chief, Rules and Directives 
Branch, Division of Administrative Services, Office of Administration, 
U. S. Nuclear Regulatory Commission, Washington, DC 20555-0001. Hand-
deliver comments to 11545 Rockville Pike, Rockville, Maryland, between 
7:15 a.m. and 4:30 p.m. on Federal workdays. Comments may also be 
submitted through the Internet by addressing electronic mail to 
[email protected].
    Those considering public comment may request a free single copy of 
draft NUREG-1556, Volume 13, by writing to the U.S. Nuclear Regulatory 
Commission, ATTN: Mrs. Sally L. Merchant, Mail Stop TWFN 9-F-31, 
Washington, DC 20555-0001.

[[Page 11510]]

Alternatively, submit requests through the Internet by addressing 
electronic mail to [email protected]. A copy of draft NUREG-1556, Volume 13, 
is also available for inspection and/or copying for a fee in the NRC 
Public Document Room, 2120 L Street, NW. (Lower Level), Washington, DC 
20555-0001.
    The Presidential Memorandum dated June 1, 1998, entitled, ``Plain 
Language in Government Writing,'' directed that the Federal 
government's writing be in plain language. The NRC requests comments on 
this licensing guidance NUREG specifically with respect to the clarity 
and effectiveness of the language used. Comments should be sent to the 
address listed above.

FOR FURTHER INFORMATION, CONTACT: Mrs. Sally L. Merchant, Mail Stop 
TWFN 9-F-31, Division of Industrial and Medical Nuclear Safety, Office 
of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555, telephone (301) 415-7874; electronic 
mail address: [email protected].

Electronic Access

    Draft NUREG-1556, Vol. 13 is available electronically by visiting 
NRC's Home Page (http://www.nrc.gov/NRC/nucmat.html).

    Dated at Rockville, Maryland, this 3rd day of March, 1999.

    For the Nuclear Regulatory Commission.
Patricia K. Holahan,
Acting Chief, Rulemaking and Guidance Branch, Division of Industrial 
and Medical Nuclear Safety, NMSS
[FR Doc. 99-5750 Filed 3-8-99; 8:45 am]
BILLING CODE 7590-01-P